Genetic Technologies Limited (GNTLF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 206.46 Thousand AUD | -36.65% |
| 2023 | 325.89 Thousand AUD | -18.15% |
| 2022 | 398.15 Thousand AUD | 417.57% |
| 2021 | 76.92 Thousand AUD | -15.83% |
| 2020 | 91.39 Thousand AUD | 186.8% |
| 2019 | 31.86 Thousand AUD | -46.0% |
| 2018 | 59 Thousand AUD | -23.19% |
| 2017 | 76.82 Thousand AUD | -53.98% |
| 2016 | 166.94 Thousand AUD | -47.42% |
| 2015 | 317.49 Thousand AUD | 49.06% |
| 2014 | 212.99 Thousand AUD | -0.37% |
| 2013 | 213.79 Thousand AUD | -32.5% |
| 2012 | 316.71 Thousand AUD | -33.13% |
| 2011 | 473.65 Thousand AUD | 59.01% |
| 2010 | 297.87 Thousand AUD | -46.2% |
| 2009 | 553.65 Thousand AUD | -35.55% |
| 2008 | 859.06 Thousand AUD | 57.96% |
| 2007 | 543.84 Thousand AUD | -7.54% |
| 2006 | 588.18 Thousand AUD | 58818500.0% |
| 2005 | 1.00 AUD | 0.0% |
| 2004 | - AUD | -100.0% |
| 2003 | 258.34 Thousand AUD | -66.96% |
| 2002 | 781.81 Thousand AUD | -68.19% |
| 2001 | 2.45 Million AUD | -39.81% |
| 2000 | 4.08 Million AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 396.7 Thousand AUD | 21.73% |
| 2024 Q4 | 206.46 Thousand AUD | 0.0% |
| 2024 FY | 206.46 Thousand AUD | -36.65% |
| 2024 Q2 | 396.7 Thousand AUD | 0.0% |
| 2023 FY | 325.89 Thousand AUD | -18.15% |
| 2023 Q4 | 325.89 Thousand AUD | 0.0% |
| 2023 Q3 | 325.89 Thousand AUD | -19.47% |
| 2023 Q1 | 404.67 Thousand AUD | 1.64% |
| 2023 Q2 | 404.67 Thousand AUD | 0.0% |
| 2022 FY | 398.15 Thousand AUD | 417.57% |
| 2022 Q3 | 398.15 Thousand AUD | 18.99% |
| 2022 Q4 | 398.15 Thousand AUD | 0.0% |
| 2022 Q2 | 334.6 Thousand AUD | 0.0% |
| 2022 Q1 | 334.6 Thousand AUD | 334.96% |
| 2021 Q4 | 76.92 Thousand AUD | 0.0% |
| 2021 Q2 | 114.06 Thousand AUD | 0.0% |
| 2021 Q1 | 114.06 Thousand AUD | 24.82% |
| 2021 FY | 76.92 Thousand AUD | -15.83% |
| 2021 Q3 | 76.92 Thousand AUD | -32.56% |
| 2020 Q4 | 91.39 Thousand AUD | 0.0% |
| 2020 Q1 | 76.52 Thousand AUD | 140.14% |
| 2020 Q2 | 76.52 Thousand AUD | 0.0% |
| 2020 Q3 | 91.39 Thousand AUD | 19.43% |
| 2020 FY | 91.39 Thousand AUD | 186.8% |
| 2019 FY | 31.86 Thousand AUD | -46.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q1 | - AUD | -100.0% |
| 2019 Q3 | 31.86 Thousand AUD | 0.0% |
| 2019 Q4 | 31.86 Thousand AUD | 0.0% |
| 2018 Q1 | - AUD | -100.0% |
| 2018 Q4 | 59 Thousand AUD | 0.0% |
| 2018 Q3 | 59 Thousand AUD | 5900600.0% |
| 2018 FY | 59 Thousand AUD | -23.19% |
| 2018 Q2 | 1.00 AUD | 0.0% |
| 2017 Q4 | 76.82 Thousand AUD | 0.0% |
| 2017 Q3 | 76.82 Thousand AUD | 7682100.0% |
| 2017 Q2 | 1.00 AUD | 0.0% |
| 2017 Q1 | 1.00 AUD | -100.0% |
| 2017 FY | 76.82 Thousand AUD | -53.98% |
| 2016 Q4 | 166.94 Thousand AUD | 0.0% |
| 2016 Q3 | 166.94 Thousand AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q1 | - AUD | -100.0% |
| 2016 FY | 166.94 Thousand AUD | -47.42% |
| 2015 Q1 | 1.00 AUD | -100.0% |
| 2015 Q3 | 317.49 Thousand AUD | 5.03% |
| 2015 Q2 | 302.28 Thousand AUD | 30228000.0% |
| 2015 FY | 317.49 Thousand AUD | 49.06% |
| 2015 Q4 | 317.49 Thousand AUD | 0.0% |
| 2014 Q2 | 472.44 Thousand AUD | 47244700.0% |
| 2014 Q1 | 1.00 AUD | -100.0% |
| 2014 Q4 | 212.99 Thousand AUD | 0.0% |
| 2014 Q3 | 212.99 Thousand AUD | -54.92% |
| 2014 FY | 212.99 Thousand AUD | -0.37% |
| 2013 Q3 | 213.79 Thousand AUD | 0.0% |
| 2013 FY | 213.79 Thousand AUD | -32.5% |
| 2013 Q4 | 213.79 Thousand AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 FY | 316.71 Thousand AUD | -33.13% |
| 2012 Q4 | 316.71 Thousand AUD | 0.0% |
| 2011 FY | 473.65 Thousand AUD | 59.01% |
| 2011 Q4 | 473.65 Thousand AUD | 0.0% |
| 2011 Q2 | 291.09 Thousand AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2010 FY | 297.87 Thousand AUD | -46.2% |
| 2010 Q4 | 369.53 Thousand AUD | 0.0% |
| 2009 FY | 553.65 Thousand AUD | -35.55% |
| 2009 Q2 | 445.08 Thousand AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 FY | 859.06 Thousand AUD | 57.96% |
| 2008 Q2 | 720.77 Thousand AUD | 0.0% |
| 2008 Q4 | 859.06 Thousand AUD | 0.0% |
| 2007 FY | 543.84 Thousand AUD | -7.54% |
| 2007 Q4 | 543.84 Thousand AUD | 0.0% |
| 2007 Q2 | 321.1 Thousand AUD | 0.0% |
| 2006 FY | 588.18 Thousand AUD | 58818500.0% |
| 2006 Q4 | 588.18 Thousand AUD | 0.0% |
| 2006 Q2 | 600.15 Thousand AUD | 0.0% |
| 2005 Q2 | - AUD | 0.0% |
| 2005 Q4 | 1.00 AUD | 0.0% |
| 2005 FY | 1.00 AUD | 0.0% |
| 2004 FY | - AUD | -100.0% |
| 2003 FY | 258.34 Thousand AUD | -66.96% |
| 2002 FY | 781.81 Thousand AUD | -68.19% |
| 2001 FY | 2.45 Million AUD | -39.81% |
| 2000 FY | 4.08 Million AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | 45.523% |
| Arrayit Corporation | 464.19 Thousand USD | 55.521% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | 72.725% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 8756.939% |
| DermTech, Inc. | 1 Million USD | 79.435% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 93.742% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 77.294% |
| iMD Companies, Inc. | 38.31 Thousand USD | -438.856% |
| IDenta Corp. | 442.28 Thousand USD | 53.317% |
| Interpace Biosciences, Inc. | 1.22 Million USD | 83.173% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | -26.563% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | 73.665% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 55158.133% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | 55.956% |
| PharmChem, Inc. | 391.93 Thousand USD | 47.321% |
| Proteome Sciences plc | 1.06 Million USD | 80.622% |
| Response Genetics, Inc | 133 Thousand USD | -55.239% |
| Rennova Health, Inc. | 242.64 Thousand USD | 14.909% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -179.4% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -115.923% |
| Todos Medical Ltd. | 1.02 Million USD | 79.778% |